143 related articles for article (PubMed ID: 4462405)
1. Bioavailability from pharmaceutical dosage forms.
Stenlake JB
Analyst; 1974 Dec; 99(1185):824-37. PubMed ID: 4462405
[No Abstract] [Full Text] [Related]
2. The general problem of drug bioavailability and its assessment in man.
Smith RN
Postgrad Med J; 1974 Nov; 50 Suppl 6():7-14. PubMed ID: 4459894
[No Abstract] [Full Text] [Related]
3. Partitioning phenomena in dosage form and biopharmaceutical design. 3. Some partitioning considerations in drug absorption, distribution, response and elimination.
Schumacher GE
Am J Hosp Pharm; 1972 Apr; 29(4):339-43. PubMed ID: 5025265
[No Abstract] [Full Text] [Related]
4. [Biological availability of drugs].
Holovkin VO
Farm Zh; 1979; (2):20-5. PubMed ID: 456507
[No Abstract] [Full Text] [Related]
5. [Bioavailability and biopharmaceutics].
Colombo BM; Colombo MM; De Fusco R
Boll Chim Farm; 1976 Mar; 115(3):231-41. PubMed ID: 1275980
[No Abstract] [Full Text] [Related]
6. Proceedings: Bioavailability and therapeutic efficacy.
Withey RJ
Rev Can Biol; 1973; 32():Suppl:21-30. PubMed ID: 4777602
[No Abstract] [Full Text] [Related]
7. [Editorial: Definition of the concepts availments and availability].
Dost FH
Klin Wochenschr; 1975 Feb; 53(4):145-6. PubMed ID: 1123894
[No Abstract] [Full Text] [Related]
8. Drug formulation and biologic availability.
Poole JW
Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
[No Abstract] [Full Text] [Related]
9. Dose-dependent drug metabolism during the absorptive phase.
Barr WH; Aceto T; Chung M; Shukur M
Rev Can Biol; 1973; 32():Suppl:33-42. PubMed ID: 4791683
[No Abstract] [Full Text] [Related]
10. Bioavailability of peroral dosage forms.
Ritschel WA
Boll Chim Farm; 1973 Mar; 112(3):137-62. PubMed ID: 4198518
[No Abstract] [Full Text] [Related]
11. [Influence of the starting materials on bioavailability of drugs].
Bagnaresi P; Bulgarelli D; Calvi A; Ferrarini G
Boll Chim Farm; 1973 Feb; 112(2):83-93. PubMed ID: 4719968
[No Abstract] [Full Text] [Related]
12. Bioavailability: some pharmaceutical factors.
Fowle AS
Trans Med Soc Lond; 1975; 91():23-32. PubMed ID: 1236035
[No Abstract] [Full Text] [Related]
13. Bioavailability, clinical effectiveness, and the public interest.
Levy G
Pharmacology; 1972; 8(1):33-43. PubMed ID: 4644654
[No Abstract] [Full Text] [Related]
14. Regional intestinal drug permeation: biopharmaceutics and drug development.
Lennernäs H
Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845
[TBL] [Abstract][Full Text] [Related]
15. Proceedings: The line-up on bioavailability.
Schneller GH
Rev Can Biol; 1973; 32():Suppl:151-5. PubMed ID: 4777598
[No Abstract] [Full Text] [Related]
16. [Drugs and the organism. II. Bioavailability].
Pflegel P; Pfeifer S
Pharmazie; 1980; 34(5-6):337-59. PubMed ID: 6893363
[No Abstract] [Full Text] [Related]
17. Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms.
Akers MJ
Int J Pharm Compd; 2017; 21(1):47-56. PubMed ID: 28346198
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability of drugs (first of two parts).
Koch-Weser J
N Engl J Med; 1974 Aug; 291(5):233-7. PubMed ID: 4600408
[No Abstract] [Full Text] [Related]
19. [Absorption and biological availability of drugs].
Uribe M
Rev Gastroenterol Mex; 1977; 42(1):2-8. PubMed ID: 616972
[TBL] [Abstract][Full Text] [Related]
20. Effect of gastric emptying on bioavailability of solid dosage forms.
Tamassia V; Simioni L; Tommasini R
Boll Chim Farm; 1978 Mar; 117(3):135-44. PubMed ID: 743364
[No Abstract] [Full Text] [Related]
[Next] [New Search]
